The class action complaint centers on the March 2025 merger announcement and a subsequent proxy statement issued in May. Plaintiffs allege these documents contained material omissions that mischaracterized the transaction as an arm's-length strategic review. According to the filing, the proxy failed to disclose the personal interest of Executive Chairman Foley in a rapid sale and omitted Bank of America Securities’ valuations regarding superior alternatives to a whole-company buyout.
In section Releases
Investors Face November Deadline in Dun & Bradstreet Merger Lawsuit
Investors who held or sold Dun & Bradstreet Holdings, Inc. stock during the 2025 merger with Clearlake Capital Group affiliates have until November 10, 2026, to seek lead plaintiff status. The Rosen Law Firm is spearheading the litigation, alleging that misleading proxy statements obscured the true value of the company.
Beyond valuation concerns, the lawsuit claims the board misstated financial projections and concealed long-standing ties between Foley and the firm's financial and legal advisors. Investors who sold DNB stock between May 13 and August 26, 2025, or those who held shares during the May 9, 2025 record date, may be eligible for compensation. While no class has been certified yet, those interested in participating or serving as a representative must act before the November deadline. Potential class members retain the right to select their own counsel or remain absent from the litigation while awaiting future developments.
Comments (0)
No comments yet. Be the first!